CXC chemokines in angiogenesis of cancer

Seminars in Cancer Biology

Volumn 14, Issue 3, 2004, Pages 195-200

  Strieter, Robert M ^a   Belperio, John A ^a   Phillips, Roderick J ^a   Keane, Michael P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Cancer; CXC chemokines; Tumor growth

Indexed keywords

ALPHA CHEMOKINE; AMINO ACID; ARGININE; CHEMOKINE; CYSTEINE; GLUTAMIC ACID; INTERFERON; LEUCINE;

ANGIOGENESIS; CANCER; CARCINOGENESIS; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; NONHUMAN; PATHOGENESIS; PROTEIN FAMILY; REVIEW;

EID: 2342524099     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2003.10.006     Document Type: Article

References (40)

1. Engerman R.L., Pfaffenenbach D., Davis M.D. Cell turnover of capillaries. Lab Invest. 17:1967;738-743
2. Tannock I.F., Hayashi H.S. The proliferation of capillary and endothelial cells. Cancer Res. 32:1972;77-82
3. Walter D.H., Dimmeler S. Endothelial progenitor cells: regulation and contribution to adult neovascularization. Herz. 27:2002;579-588
4. Moldovan N.I. Tissular insemination of progenitor endothelial cells: the problem, and a suggested solution. Adv. Exp. Med. Biol. 522:2003;99-113
5. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436-445
6. Rollins B.J. Chemokines. Blood. 90:1997;909-928
7. Balkwill F. The molecular and cellular biology of the chemokines. J. Viral Hepat. 5:1998;1-14
8. Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:1995;27348-27357
9. Nor J.E., Christensen J., Liu J., Peters M., Mooney D.J., Strieter R.M., et al. Up-regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res. 61:2001;2183-2188
10. Li A., Dubey S., Varney M.L., Dave B.J., Singh R.K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170:2003;3369-3376
11. Dong G., Chen Z., Li Z.Y., Yeh N.T., Bancroft C.C., Van Waes C. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res. 61:2001;5911-5918
12. Hirata A., Ogawa S., Kometani T., Kuwano T., Naito S., Kuwano M., et al. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res. 62:2002;2554-2560
13. Bachelder R.E., Wendt M.A., Mercurio A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62:2002;7203-7206
14. Salcedo R., Oppenheim J.J. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation. 10:2003;359-370
15. Kijowski J., Baj-Krzyworzeka M., Majka M., Reca R., Marquez L.A., Christofidou-Solomidou M., et al. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells. 19:2001;453-466
16. Salcedo R., Wasserman K., Young H.A., Grimm M.C., Howard O.M., Anver M.R., et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am. J. Pathol. 154:1999;1125-1135
17. Phillips R.J., Burdick M.D., Lutz M., Belperio J.A., Keane M.P., Strieter R.M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am. J. Respir. Crit. Care Med. 167:2003;1676-1686
18. Smith D.R., Polverini P.J., Kunkel S.L., Orringer M.B., Whyte R.I., Burdick M.D., et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med. 179:1994;1409-1415
19. Belperio J.A., Keane M.P., Arenberg D.A., Addison C.L., Ehlert J.E., Burdick M.D., et al. CXC chemokines in angiogenesis. J. Leukoc. Biol. 68:2000;1-8
20. Arenberg D.A., Kunkel S.L., Polverini P.J., Glass M., Burdick M.D., Strieter R.M. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97:1996;2792-2802
21. Arenberg D.A., Kunkel S.L., Polverini P.J., Morris S.B., Burdick M.D., Glass M.C., et al. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184:1996;981-992
22. Addison C.L., Daniel T.O., Burdick M.D., Liu H., Ehlert J.E., Xue Y.Y., et al. The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR(+) CXC Chemokine-Induced Angiogenic Activity. J. Immunol. 165:2000;5269-5277
23. Murdoch C., Monk P.N., Finn A. Cxc chemokine receptor expression on human endothelial cells. Cytokine. 11:1999;704-712
24. Salcedo R., Resau J.H., Halverson D., Hudson E.A., Dambach M., Powell D., et al. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells [in process citation]. FASEB J. 14:2000;2055-2064
25. Heidemann J., Ogawa H., Dwinell M.B., Rafiee P., Maaser C., Gockel H.R., et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J. Biol. Chem. 278:2003;8508-8515
26. Strieter RM, Belperio JA, Arenberg DA, Smith MI, Burdick MD, Keane MP. CXC chemokine in angiogenesis. In: Ransohoff RM, Suzuki K, Proudfoot AEI, Hickey WF, editors. Universies in delicate balance: chemokines and the nervous system. Amsterdam, The Netherlands: Elsevier Science B.V.; 2002. p. 129-48.
27. Soto H., Wang W., Strieter R.M., Copeland N.G., Gilbert D.J., Jenkins N.A., et al. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8205-8210
28. Romagnani P., Annunziato F., Lasagni L., Lazzeri E., Beltrame C., Francalanci M., et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107:2001;53-63
29. Lasagni L., Francalanci M., Annunziato F., Lazzeri E., Giannini S., Cosmi L., et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197:2003;1537-1549
30. Yoneda J., Kuniyasu H., Crispens M.A., Price J.E., Bucana C.D., Fidler I.J. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst. 90:1998;447-454
31. Gawrychowski K., Skopinska-Rozewska E., Barcz E., Sommer E., Szaniawska B., Roszkowska-Purska K., et al. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites. Eur. J. Gynaecol. Oncol. 19:1998;262-264
32. Arenberg D.A., Keane M.P., DiGiovine B., Kunkel S.L., Morris S.B., Xue Y.Y., et al. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Invest. 102:1998;465-472
33. Bostwick D.G., Iczkowski K.A. Microvessel density in prostate cancer: prognostic and therapeutic utility. Semin. Urol. Oncol. 16:1998;118-123
34. Fregene T.A., Khanuja P.S., Noto A.C., Gehani S.K., Van Egmont E.M., Luz D.A., et al. Tumor-associated angiogenesis in prostate cancer. Anticancer Res. 13:1993;2377-2381
35. Veltri R.W., Miller M.C., Zhao G., Ng A., Marley G.M., Wright G.L. Jr., et al. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology. 53:1999;139-147
36. Moore B.B., Arenberg D.A., Stoy K., Morgan T., Addison C.L., Morris S.B., et al. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am. J. Pathol. 154:1999;1503-1512
37. Sgadari C., Angiolillo A.L., Cherney B.W., Pike S.E., Farber J.M., Koniaris L.G., et al. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;13791-13796
38. Sgadari C., Farber J.M., Angiolillo A.L., Liao F., Teruya-Feldstein J., Burd P.R., et al. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood. 89:1997;2635-2643
39. Addison C.L., Arenberg D.A., Morris S.B., Xue Y.Y., Burdick M.D., Mulligan M.S., et al. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. Hum. Gene. Ther. 11:2000;247-261
40. Feldman A.L., Friedl J., Lans T.E., Libutti S.K., Lorang D., Miller M.S., et al. Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts. Int. J. Cancer. 99:2002;149-153